A soluble thymic stromal lymphopoietin (TSLP) antagonist, TSLPR-immunoglobulin, reduces the severity of allergic disease by regulating pulmonary dendritic cells

Clinical and Experimental Immunology

Volumn 164, Issue 2, 2011, Pages 256-264

  Zhang, F ^a   Huang, G ^b   Hu, B ^a   Song, Y ^a   Shi, Y ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Asthma bronchiale; Dendritic cells; Ovalbumin; Soluble receptor; Thymic stromal lymphopoietin

Indexed keywords

ALLERGEN; B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CYTOKINE RECEPTOR ANTAGONIST; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; THYMIC STROMAL LYMPHOPOIETIN RECEPTOR IMMUNOGLOBULIN; UNCLASSIFIED DRUG;

AIRWAY; ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CELL FUNCTION; CELL STRAIN COS7; CELL TRANSFER; CONTROLLED STUDY; DENDRITIC CELL; DISEASE SEVERITY; DOWN REGULATION; DRUG EFFECT; DRUG PURIFICATION; EOSINOPHIL; FEMALE; GENETIC TRANSFECTION; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; INFLAMMATORY INFILTRATE; LUNG ALVEOLUS CELL; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION; SIGNAL TRANSDUCTION; TH2 CELL;

ANIMALS; ANTIGENS, CD40; ANTIGENS, CD80; ANTIGENS, CD86; ASTHMA; CERCOPITHECUS AETHIOPS; COS CELLS; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOGLOBULIN E; IMMUNOGLOBULINS; LUNG; MICE; MICE, INBRED BALB C; OVALBUMIN; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CYTOKINE; RECOMBINANT FUSION PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 79953781744     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04328.x     Document Type: Article

References (33)

1. Komai M, Tanaka H, Masuda T etal. Role of Th2 responses in the development of allergen-induced airway remodelling in a murine model of allergic asthma. Br J Pharmacol 2003; 138:912-20.
2. Mazzarella G, Bianco A, Catena E, De Palma R, Abbate GF. Th1/Th2 lymphocyte polarization in asthma. Allergy 2000; 55 (Suppl. 61):6-9.
3. Renauld JC. New insights into the role of cytokines in asthma. J Clin Pathol 2001; 54:577-89.
4. Kuipers H, Lambrecht BN. The interplay of dendritic cells, Th2 cells and regulatory T cells in asthma. Curr Opin Immunol 2004; 16:702-8.
5. Lambrecht BN, Salomon B, Klatzmann D, Pauwels RA. Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J Immunol 1998; 160:4090-7.
6. Amati L, Pepe M, Passeri ME, Mastronardi ML, Jirillo E, Covelli V. Toll-like receptor signaling mechanisms involved in dendritic cell activation: potential therapeutic control of T cell polarization. Curr Pharm Des 2006; 12:4247-54.
7. Idzko M, Hammad H, van Nimwegen M etal. Inhaled iloprost suppresses the cardinal features of asthma via inhibition of airway dendritic cell function. J Clin Invest 2007; 117:464-72.
8. Headley MB, Zhou B, Shih WX, Aye T, Comeau MR, Ziegler SF. TSLP conditions the lung immune environment for the generation of pathogenic innate and antigen-specific adaptive immune responses. J Immunol 2009; 182:1641-7.
9. Ito T, Wang YH, Duramad O etal. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med 2005; 202:1213-23.
10. He R, Geha RS. Thymic stromal lymphopoietin. Ann NY Acad Sci 2010; 1183:13-24.
11. Al-Shami A, Spolski R, Kelly J, Keane-Myers A, Leonard WJ. A role for TSLP in the development of inflammation in an asthma model. J Exp Med 2005; 202:829-39.
12. Pandey A, Ozaki K, Baumann H etal. Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nat Immunol 2000; 1:59-64.
13. Isaksen DE, Baumann H, Trobridge PA, Farr AG, Levin SD, Ziegler SF. Requirement for stat5 in thymic stromal lymphopoietin-mediated signal transduction. J Immunol 1999; 163:5971-7.
14. Rochman Y, Kashyap M, Robinson GW etal. Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7-induced signaling. Proc Natl Acad Sci USA 2010; 107:19455-60.
15. Osborn MJ, Ryan PL, Kirchhof N, Panoskaltsis-Mortari A, Mortari F, Tudor KS. Overexpression of murine TSLP impairs lymphopoiesis and myelopoiesis. Blood 2004; 103:843-51.
16. Al-Shami A, Spolski R, Kelly J etal. A role for thymic stromal lymphopoietin in CD4(+) T cell development. J Exp Med 2004; 200:159-68.
17. Henderson WR Jr, Chi EY, Albert RK etal. Blockade of CD49d (alpha4 integrin) on intrapulmonary but not circulating leukocytes inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma. J Clin Invest 1997; 100:3083-92.
18. Ahrens B, Gruber C, Rha RD etal. BCG priming of dendritic cells enhances T regulatory and Th1 function and suppresses allergen-induced Th2 function in vitro and in vivo. Int Arch Allergy Immunol 2009; 150:210-20.
19. Sung S, Rose CE, Fu SM. Intratracheal priming with ovalbumin- and ovalbumin 323-339 peptide-pulsed dendritic cells induces airway hyperresponsiveness, lung eosinophilia, goblet cell hyperplasia, and inflammation. J Immunol 2001; 166:1261-71.
20. Lambrecht BN, De Veerman M, Coyle AJ, Gutierrez-Ramos JC, Thielemans K, Pauwels RA. Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J Clin Invest 2000; 106:551-9.
21. Huang TJ, MacAry PA, Eynott P etal. Allergen-specific Th1 cells counteract efferent Th2 cell-dependent bronchial hyperresponsiveness and eosinophilic inflammation partly via IFN-gamma. J Immunol 2001; 166:207-17.
22. Soroosh P, Doherty TA. Th9 and allergic disease. Immunology 2009; 127:450-8.
23. Nakae S, Komiyama Y, Nambu A etal. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 2002; 17:375-87.
24. Akbari O, Stock P, Meyer E etal. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 2003; 9:582-8.
25. Kearley J, Barker JE, Robinson DS, Lloyd CM. Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J Exp Med 2005; 202:1539-47.
26. Hamelmann E, Oshiba A, Paluh J etal. Requirement for CD8+ T cells in the development of airway hyperresponsiveness in a marine model of airway sensitization. J Exp Med 1996; 183:1719-29.
27. Lahn M, Kanehiro A, Takeda K etal. Negative regulation of airway responsiveness that is dependent on gammadelta T cells and independent of alphabeta T cells. Nat Med 1999; 5:1150-6.
28. Provoost S, Maes T, Willart MA, Joos GF, Lambrecht BN, Tournoy KG. Diesel exhaust particles stimulate adaptive immunity by acting on pulmonary dendritic cells. J Immunol 2010; 184:426-32.
29. Idzko M, Hammad H, van Nimwegen M etal. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat Med 2007; 13:913-19.
30. Oyoshi MK, He R, Kumar L, Yoon J, Geha RS. Cellular and molecular mechanisms in atopic dermatitis. Adv Immunol 2009; 102:135-226.
31. Zhang Z, Hener P, Frossard N etal. Thymic stromal lymphopoietin overproduced by keratinocytes in mouse skin aggravates experimental asthma. Proc Natl Acad Sci USA 2009; 106:1536-41.
32. Allakhverdi Z, Comeau MR, Jessup HK etal. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med 2007; 204:253-8.
33. Omori M, Ziegler S. Induction of IL-4 expression in CD4(+) T cells by thymic stromal lymphopoietin. J Immunol 2007; 178:1396-404.